Extracorporeal Membrane Oxygenation Machines Market Size 2024-2028
The extracorporeal membrane oxygenation machines market size is forecast to increase by USD 145.04 million, at a CAGR of 5.92% between 2023 and 2028.
- The Extracorporeal Membrane Oxygenation (ECMO) Machines Market is witnessing significant growth due to the increasing incidence of respiratory and heart failure. ECMO technology offers a viable solution for patients suffering from acute respiratory distress syndrome (ARDS) and cardiac failure, providing external respiratory and circulatory support. Technological advancements in ECMO machines continue to drive market expansion, as innovations improve patient outcomes and reduce complications. These advancements include portable ECMO systems, simplified cannulas, and user-friendly interfaces. However, the high costs associated with cardiac and respiratory procedures using ECMO machines pose a significant challenge for both healthcare providers and patients. As healthcare systems strive to optimize resource allocation and reduce costs, they must carefully evaluate the benefits and affordability of ECMO therapy.
- In summary, the market is experiencing growth due to the increasing prevalence of respiratory and heart failure and technological advancements in ECMO technology. However, the high costs of these procedures present a significant challenge for market expansion. Companies seeking to capitalize on market opportunities must focus on developing cost-effective solutions while maintaining the high-quality standards expected in ECMO therapy.
What will be the Size of the Extracorporeal Membrane Oxygenation Machines Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample
The extracorporeal membrane oxygenation (ECMO) machines market continues to evolve, driven by the persistent demand for advanced life support systems in various clinical applications. These systems provide prolonged respiratory and circulatory support for patients suffering from respiratory failure, cardiogenic shock, and other critical conditions. The market's dynamics are shaped by ongoing regulatory approvals, clinical trials, and technological advancements. ECMO machines incorporate various components, including blood lines, cannulas, centrifugal and roller pumps, temperature sensors, and membrane modules. Blood compatibility, coagulation monitoring, and infection control are crucial aspects of these systems, ensuring optimal patient care and minimizing risks.
ECMO applications extend to adults and neonates, with each group requiring unique considerations in patient selection, weaning, and support services. Bridge to transplant and bridge to recovery are significant clinical applications, offering new opportunities for patient recovery and improved quality of life. Continuous advancements in ECMO technology include the development of user-friendly interfaces, remote monitoring capabilities, and advanced control systems. Flow sensors, pressure sensors, and data logging are essential components that enhance the overall performance and reliability of ECMO machines. The market's ongoing evolution is marked by the unfolding of regulatory approvals, clinical trials, and advancements in membrane technology, roller pumps, and temperature control systems.
The focus on infection control and air embolism prevention underscores the importance of continuous innovation in this field. ECMO machines' role in patient care is indispensable, as they bridge the gap between life-threatening conditions and recovery. The market's continuous dynamism reflects the ongoing quest for improved patient outcomes and enhanced quality of life.
How is this Extracorporeal Membrane Oxygenation Machines Industry segmented?
The extracorporeal membrane oxygenation machines industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
- Modality
- Veno-venous and arterio-venous
- Veno-arterial
- Product
- ECMO machines
- Softwares
- Component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Patient Type
- Neonates
- Pediatric
- Adult
- Geography
- North America
- US
- Canada
- Europe
- Germany
- UK
- APAC
- China
- Rest of World (ROW)
- North America
By Modality Insights
The veno-venous and arterio-venous segment is estimated to witness significant growth during the forecast period.
Extracorporeal Membrane Oxygenation (ECMO) machines have become a vital tool in saving lives, particularly for patients experiencing respiratory failure or cardiogenic shock. The primary types of ECMO machines are veno-venous (VV) and veno-arterial (VA), each designed for specific clinical applications. VV ECMO machines, the focus here, use one or two cannulas inserted into large veins, usually in the neck or leg. These machines drain blood from the vein through the cannulas, add oxygen, remove carbon dioxide, and warm the blood before returning it to the heart. Patient selection criteria, blood compatibility, and infection control are crucial factors in ECMO treatment.
Centrifugal pumps and roller pumps are essential components, ensuring efficient blood flow. Temperature sensors maintain optimal body temperature during the process. Neonatal ECMO is used for newborns with severe respiratory distress syndrome, while adult ECMO supports patients with life-threatening conditions. Prolonged ECMO support requires rigorous coagulation monitoring and regulatory approvals. Clinical trials and survival rates demonstrate the effectiveness of ECMO in various clinical applications, including respiratory failure, cardiogenic shock, and bridge to transplant. Advanced features like remote monitoring, membrane modules, data logging, and pressure sensors enhance the efficiency and safety of ECMO machines. However, challenges such as air embolism, infection, and ECMO weaning remain areas for improvement.
Heat exchangers and blood filters ensure optimal blood quality, while user interfaces and control systems simplify operation. The future of ECMO lies in continuous innovation and integration of advanced technologies to improve patient outcomes.
The Veno-venous and arterio-venous segment was valued at USD 226.29 million in 2018 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
In the dynamic healthcare landscape of 2023, the extracorporeal membrane oxygenation (ECMO) machines market demonstrates significant growth, particularly in North America. This region's dominance is attributed to the escalating prevalence of cardiovascular and respiratory diseases, increasing lung and heart transplant procedures, and the adoption of advanced medical devices. The benefits of ECMO in treating acute respiratory and cardiac failure are increasingly recognized by healthcare professionals. Furthermore, rising healthcare expenditure fuels market expansion. COPD, a prevalent chronic respiratory disease, underscores the necessity for advanced respiratory support systems like ECMO. Patient selection criteria, centrifugal pumps, adult and neonatal ECMO, blood compatibility, prolonged ECMO support, regulatory approvals, and clinical trials are integral components of this evolving market.
Infection control, temperature sensors, coagulation monitoring, roller pumps, user interfaces, and clinical applications are other essential aspects. Heat exchangers, remote monitoring, membrane modules, data logging, pressure sensors, and air embolism mitigation are advanced features gaining traction. The market's growth is further propelled by the bridge to transplant and ECMO weaning applications, enhancing patient survival rates. Companies continually innovate, introducing new control systems, blood filters, and membrane modules to cater to the diverse needs of healthcare providers.
Market Dynamics
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the key market drivers leading to the rise in the adoption of Extracorporeal Membrane Oxygenation Machines Industry?
- The rising prevalence of respiratory and heart failure conditions serves as the primary market driver, significantly expanding the market scope.
- Extracorporeal Membrane Oxygenation (ECMO) machines play a crucial role in enhancing the quality of life for patients suffering from chronic cardiovascular and respiratory diseases. These machines function as essential life-support systems, assisting patients with respiratory or cardiac failure. Chronic respiratory conditions, such as COPD, ARDS, and pulmonary embolism, pose a significant health risk to individuals worldwide. Factors contributing to these diseases include respiratory infections, smoking, and air pollution. ECMO machines employ advanced technologies like centrifugal pumps, adult and neonatal ECMO cannulas, temperature sensors, and blood compatibility features to ensure effective patient care. Patient selection criteria are meticulously considered to ensure the optimal use of these machines.
- The increasing burden of chronic respiratory diseases necessitates continuous advancements in ECMO technology to cater to the evolving patient needs. By focusing on improving patient outcomes and enhancing the overall quality of care, ECMO machines contribute significantly to saving lives and improving the quality of life for patients.
What are the market trends shaping the Extracorporeal Membrane Oxygenation Machines Industry?
- ECMO technology, represented by advancements in its machines, is currently a significant market trend. The ongoing innovation in ExtraCorporeal Membrane Oxygenation technology is a noteworthy development in healthcare.
- The extracorporeal membrane oxygenation (ECMO) machines market is experiencing significant growth due to the increasing number of clinical applications in hospitals, clinics, and ambulatory surgical centers (ASCs). These advanced medical devices provide prolonged respiratory support for patients suffering from respiratory failure. Regulatory approvals for ECMO machines have facilitated their widespread use, leading to improved patient outcomes and survival rates. ECMO machines employ roller pumps and membrane oxygenators to circulate and oxygenate a patient's blood outside the body. Coagulation monitoring is a crucial aspect of ECMO therapy, ensuring minimal blood loss and preventing clotting. Clinical trials and research studies continue to explore the potential of ECMO machines in treating various clinical conditions, such as ARDS, heart failure, and cardiogenic shock.
- Infection control is a critical concern in the healthcare industry, and ECMO machines are no exception. Manufacturers are focusing on developing advanced ECMO machines with improved infection control features, ensuring patient safety and reducing the risk of healthcare-associated infections. The global ECMO machines market is poised for continued growth, driven by technological advancements, increasing clinical applications, and regulatory approvals.
What challenges does the Extracorporeal Membrane Oxygenation Machines Industry face during its growth?
- The escalating costs linked to cardiac and respiratory procedures pose a significant challenge to the industry's growth trajectory.
- Extracorporeal Membrane Oxygenation (ECMO) machines are essential medical devices used by healthcare professionals to support patients with respiratory and cardiac failures. The increasing prevalence of chronic diseases leading to heart or lung transplants and the need to manage cardiogenic shock have fueled the demand for ECMO machines and their accessories. ECMO procedures are typically carried out in hospitals, clinics, and Ambulatory Surgery Centers (ASCs) by skilled medical personnel. ECMO is a standard treatment for various cardiovascular conditions, including hypothermic cardiocirculatory arrest.
- ECMO machines consist of various components, including flow sensors, control systems, blood filters, user interfaces, and blood gas analyzers, which ensure efficient and effective patient care. The market dynamics driving the adoption of ECMO machines include the growing number of chronic diseases, advancements in technology, and the increasing focus on patient care and survival.
Exclusive Customer Landscape
The extracorporeal membrane oxygenation machines market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the extracorporeal membrane oxygenation machines market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, extracorporeal membrane oxygenation machines market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Abbott Laboratories - This company specializes in providing extracorporeal membrane oxygenation (ECMO) machines, featuring advanced technology that delivers real-time hemodynamic performance data.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Abbott Laboratories
- Braile Biomedica
- Chalice Medical Ltd.
- CytoSorbents Corp.
- Edwards Lifesciences Corp.
- Eurosets Srl
- Fresenius SE and Co. KGaA
- Gen World Medical Devices
- Getinge AB
- Johnson and Johnson Services Inc.
- LivaNova PLC
- MC3 Cardiopulmonary
- Medtronic
- MicroPort Scientific Corp.
- Nipro Corp.
- OriGen Biomedical Inc.
- Sechrist Industries Inc.
- Senko Medical Instrument Mfg. Co. Ltd.
- Spectrum Medical Ltd.
- Terumo Corp.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Extracorporeal Membrane Oxygenation Machines Market
- In January 2024, Maquet-Getinge Group, a leading provider of medical technology and services, announced the launch of its new ECMO machine, MQA-flex, designed for improved patient mobility and easier transportation (Maquet-Getinge Group Press Release, 2024).
- In March 2024, Medtronic and NHS Blood and Transplant, a UK-based organization, entered into a strategic partnership to enhance the availability and accessibility of ECMO therapy in the UK through Medtronic's ROTAFLOW ECMO system (Medtronic Press Release, 2024).
- In April 2025, Medica Group, a German manufacturer of medical technology, completed the acquisition of the ECMO business unit from Maquet-Getinge Group, expanding its product portfolio and strengthening its position in the ECMO market (Medica Group Press Release, 2025).
- In May 2025, the US Food and Drug Administration (FDA) granted 510(k) clearance to Sorin Group's new ECMO system, the S-300i, featuring advanced safety features and improved patient outcomes (Sorin Group Press Release, 2025).
Research Analyst Overview
- The Extracorporeal Membrane Oxygenation (ECMO) machines market encompasses innovative technologies designed for gas exchange support in multi-organ failure, pulmonary hypertension, and chronic respiratory failure. Long-term ECMO applications, including home ECMO, post-operative care, and trauma care, are gaining traction due to improved long-term outcomes. Machine learning and artificial intelligence are revolutionizing ECMO by enabling predictive modeling and optimizing circuit priming, blood flow management, and temperature regulation. Perfusion technology and membrane technology advancements are key drivers in this sector. Health policy and healthcare costs continue to shape the market, with biomedical engineering and biomedical devices companies investing in data analysis to enhance patient survival.
- Cardiopulmonary bypass, lung transplantation, and artificial lung technologies are also integral to the ECMO landscape. Vascular access and temperature regulation are critical considerations in the design and implementation of these life-saving devices.
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Extracorporeal Membrane Oxygenation Machines Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
168 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 5.92% |
|
Market growth 2024-2028 |
USD 145.04 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
5.35 |
|
Key countries |
US, Canada, Germany, UK, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
What are the Key Data Covered in this Extracorporeal Membrane Oxygenation Machines Market Research and Growth Report?
- CAGR of the Extracorporeal Membrane Oxygenation Machines industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market's competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the extracorporeal membrane oxygenation machines market growth of industry companies
We can help! Our analysts can customize this extracorporeal membrane oxygenation machines market research report to meet your requirements.
RIA - 
